Prior studies had identified neuropilin-1 as a target of miR-24, and indeed, that neuropilin-1 is a necessary co-factor of SARS-CoV-2 infection and is associated with COVID-19-associated CBV events. The gene discussed is NRP1; the disease is COVID-19.